{"gene":"TXNIP","run_date":"2026-04-28T21:43:00","timeline":{"discoveries":[{"year":2000,"finding":"TXNIP (VDUP1) directly binds to thioredoxin (TRX) via a region spanning amino acids 155–225 of TXNIP; interaction requires Cys32 and Cys35 of TRX and is abolished by mutation of these cysteines to serines, establishing TXNIP as an endogenous inhibitor of TRX.","method":"Yeast two-hybrid screen with HeLa cDNA library, deletion and point-mutation mapping","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — reconstitution-equivalent yeast two-hybrid with site-directed mutagenesis defining the binding interface; foundational paper replicated across many labs","pmids":["10814541"],"is_preprint":false},{"year":2005,"finding":"TXNIP (VDUP1) interacts with JAB1 and blocks JAB1-mediated cytoplasmic translocation of p27(kip1), thereby stabilizing p27(kip1) protein levels and inhibiting cell proliferation; VDUP1−/− fibroblasts proliferate faster with reduced p27(kip1).","method":"Co-immunoprecipitation, KO fibroblast phenotyping, nuclear export rescue assay, AP-1 reporter assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus genetic KO with defined molecular and cellular phenotype","pmids":["15930262"],"is_preprint":false},{"year":2006,"finding":"TXNIP (VDUP1) associates with the β-domain of pVHL and enhances pVHL–HIF1α interaction, mediating nuclear export and degradation of HIF1α via CRM1-dependent pathway; blocking TXNIP nuclear export signal or using leptomycin B prevents HIF1α destabilization and restores cell invasiveness.","method":"Co-immunoprecipitation, nuclear export signal mutation, leptomycin B treatment, invasion assays, tumor xenograft","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, mutagenesis of NES, and functional rescue; multiple orthogonal methods in single study","pmids":["18062927"],"is_preprint":false},{"year":2006,"finding":"Glucocorticoid receptor (GR) transcriptionally induces TXNIP expression through a functional glucocorticoid response element (GRE) in the TXNIP promoter; GFP-TXNIP overexpression is sufficient to induce apoptosis, and siRNA knockdown of TXNIP inhibits dexamethasone-induced apoptosis in T-cell lymphoma cells.","method":"Promoter deletion/mutation analysis, reporter assays, RU486 blockade, RNA interference, GFP-TXNIP overexpression with apoptosis readout","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 — promoter mutagenesis, reporter assays, and functional RNAi rescue; multiple orthogonal methods","pmids":["16301999"],"is_preprint":false},{"year":2011,"finding":"Thioredoxin binding to TXNIP stabilizes TXNIP protein by protecting it from proteasomal degradation; a Txnip C247S mutant that cannot bind thioredoxin is degraded more rapidly. TXNIP inhibits adipogenesis directly, and this activity requires its PPXY motifs that mediate E3 ubiquitin ligase binding; adipogenic stimulants promote Txnip-thioredoxin dissociation leading to Txnip degradation and permitting adipocyte differentiation.","method":"In vitro differentiation assays, proteasome inhibitor studies, mutagenesis of C247S and PPXY motifs, thioredoxin overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical reconstitution with mutagenesis (C247S, PPXY) and functional differentiation readout; single study with multiple orthogonal approaches","pmids":["21705327"],"is_preprint":false},{"year":2009,"finding":"TXNIP transcription is induced by adenosine-containing molecules through the carbohydrate response element (ChoRE) in the TXNIP promoter in a glucose-dependent manner; MondoA and Max-like protein X (Mlx) are the transcription factors conveying these signals to the TXNIP promoter.","method":"Promoter reporter assays, ChREBP/MondoA overexpression, adenosine analog treatments","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assays with transcription factor identification; single lab study","pmids":["19246513"],"is_preprint":false},{"year":2011,"finding":"TXNIP is expressed in nutrient-sensing neurons of the mediobasal hypothalamus (MBH); downregulation of MBH TXNIP by lentiviral shRNA prevents diet-induced obesity and insulin resistance, regulating adipose tissue metabolism and glucose homeostasis.","method":"Lentiviral shRNA knockdown in mice, stereotaxic injection, metabolic phenotyping (glucose tolerance, body weight, adiposity)","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vivo loss-of-function with defined metabolic phenotype; single study","pmids":["21508227"],"is_preprint":false},{"year":2012,"finding":"TXNIP overexpression in Agrp neurons increases diet-induced obesity and adiposity by decreasing energy expenditure without affecting food intake; Agrp-specific TXNIP deletion protects against diet-induced obesity and improves glucose tolerance, acting through central leptin sensitivity and regulation of lipolysis.","method":"Agrp-Ires-cre × Txnip-flox conditional KO and lentiviral gain-of-function, metabolic cage phenotyping, glucose clamps","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — bidirectional genetic manipulation (KO + OE) in cell-type-specific manner with defined physiological phenotypes","pmids":["22815502"],"is_preprint":false},{"year":2018,"finding":"TXNIP promotes internalization and lysosomal degradation of GLUT1, reducing glucose uptake at the plasma membrane; ZFP36 (an mRNA decay factor) induced downstream of hyaluronidase/receptor tyrosine kinase signaling targets TXNIP transcripts for degradation, thereby enriching GLUT1 at the plasma membrane and increasing glycolysis.","method":"Unbiased glycolytic driver screen, hyaluronidase treatment of cells and xenografts, ZFP36 mRNA decay assay, GLUT1 surface localization (flow cytometry/imaging), glucose uptake assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (transcriptomics, mRNA decay, surface receptor quantification, xenograft); published in high-impact journal with comprehensive mechanistic validation","pmids":["30197082"],"is_preprint":false},{"year":2016,"finding":"TXNIP interacts with class I GLUTs through its C-terminal arrestin (C-ARR) domain; upon intracellular ROS increase, TXNIP robustly binds GLUTs, promoting their surface downregulation and lysosomal degradation via a di-leucine (LL) endocytic motif, thereby suppressing glycolysis, hexosamine biosynthesis, and the pentose phosphate pathway.","method":"Co-immunoprecipitation, domain-deletion mapping (C-ARR), mutagenesis of LL endocytic motif, glucose uptake assays, lysosomal degradation assays, metabolic flux analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — domain mutagenesis combined with biochemical interaction mapping and functional metabolic readouts; mechanistically comprehensive","pmids":["38329960"],"is_preprint":false},{"year":2019,"finding":"Under ER stress, TXNIP is phosphorylated/activated by CHOP upregulation and shuttles from the nucleus to mitochondria, where it binds mitochondrial Trx2; this releases ASK1 to induce mitochondria-dependent apoptosis and liberates TXNIP to associate with mitochondrial NLRP3 to activate the inflammasome. CHOP deletion blocks TXNIP mitochondrial translocation and suppresses both pathways.","method":"Chop−/− and Txnip−/− mice, 68Ga-Galuminox mitochondrial ROS imaging, fractionation, Co-IP, nephrotic syndrome genetic model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic models (two KO strains), molecular imaging, Co-IP, and subcellular fractionation with functional apoptosis/inflammasome readouts","pmids":["35994650"],"is_preprint":false},{"year":2020,"finding":"TXNIP directly interacts with PRKAA (AMPKα) to positively regulate its activity, leading to MTORC1 inactivation and nuclear translocation of TFEB, thereby promoting autophagy and fatty acid oxidation in hepatocytes; Txnip-KO mice show impaired autophagy and exacerbated steatohepatitis.","method":"Co-immunoprecipitation, Txnip-KO mice fed MCD diet, rapamycin rescue, Atg7 siRNA epistasis, TFEB nuclear translocation imaging","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 — Co-IP establishing direct TXNIP–PRKAA interaction, KO phenotype, and epistasis rescue with multiple genetic and pharmacological tools","pmids":["33190588"],"is_preprint":false},{"year":2018,"finding":"Ras suppresses TXNIP protein synthesis by reducing the rate of ribosome translocation through the TXNIP coding sequence; codon randomization/optimization did not relieve repression, but the N-terminal nascent TXNIP polypeptide is the target for Ras-dependent translational repression.","method":"Polysome profiling, ribosome transit assay, codon randomization/optimization mutagenesis, Ras activation system","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — mechanistic dissection using ribosome profiling and systematic mutagenesis; defines translational elongation as Ras target","pmids":["30037981"],"is_preprint":false},{"year":2019,"finding":"O-GlcNAcylation of TXNIP by OGT in response to high glucose promotes the interaction of TXNIP with NLRP3 in pancreatic β-cells; reducing TXNIP O-GlcNAcylation via OGA overexpression destabilizes this interaction and reduces inflammasome-dependent IL-1β cleavage.","method":"O-GlcNAc immunoprecipitation, OGT/OGA overexpression and inhibitor studies, Co-IP of TXNIP–NLRP3, IL-1β ELISA in human and rat islets","journal":"Frontiers in endocrinology","confidence":"High","confidence_rationale":"Tier 2 — biochemical identification of PTM (O-GlcNAcylation) on TXNIP with bidirectional manipulation showing effect on TXNIP–NLRP3 interaction and downstream IL-1β; validated in primary human islets","pmids":["31164864"],"is_preprint":false},{"year":2015,"finding":"CD36 scavenger receptor mediates ceramide-induced NF-κB activation, which in turn upregulates TXNIP expression and NF-κB-TXNIP signaling in pancreatic β-cells; SSO (irreversible CD36 inhibitor) blocks ceramide-induced TXNIP induction and apoptosis, placing CD36 upstream of TXNIP in this pathway.","method":"SSO pharmacological blockade, NF-κB nuclear translocation assay (SN50 peptide), TXNIP gene/protein induction, apoptosis assays in INS-1 cells and primary islets","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2–3 — pharmacological epistasis and NF-κB inhibition defining pathway order; single lab","pmids":["26297980"],"is_preprint":false},{"year":2015,"finding":"4-Hydroxynonenal (4-HNE) from foam cells activates PPARδ in vascular endothelial cells, leading to TXNIP upregulation; molecular manipulation of TXNIP expression confirmed its role in foam cell-induced vascular endothelial cell senescence.","method":"Co-culture transwell system, 4-HNE scavenging, siRNA/overexpression of TXNIP, PPARδ pharmacological modulation, senescence-associated β-galactosidase assay, immunofluorescence of human carotid plaques","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — RNAi confirmation of TXNIP role plus pathway mapping via PPARδ inhibitors; validated in human tissue","pmids":["25754218"],"is_preprint":false},{"year":2016,"finding":"Hyperglycemia induces activating histone marks (H3K9ac, H3K4me3, H3K4me1) and reduces repressive H3K27me3 at the TXNIP promoter in kidney mesangial cells and diabetic mouse kidneys; histone acetyltransferase p300 inhibitor C646 reverses glucose-stimulated TXNIP expression, establishing epigenetic histone acetylation as a mechanism of glucose-induced TXNIP transcription.","method":"ChIP for histone marks, histone acetyltransferase inhibitor (C646) and HDAC inhibitor (TSA), diabetic mouse kidney model, mesangial cell culture","journal":"Kidney international","confidence":"High","confidence_rationale":"Tier 2 — ChIP with pharmacological perturbation of histone marks in both in vivo and in vitro models; multiple orthogonal approaches","pmids":["26806835"],"is_preprint":false},{"year":2021,"finding":"TXNIP directly binds STAT3 (demonstrated by Co-IP) and activates STAT3 signaling; TXNIP overexpression in tubular cells upregulates senescence markers and promotes a profibrotic response, which is suppressed by a STAT3 inhibitor, placing TXNIP upstream of STAT3 in age-related renal fibrosis.","method":"Co-immunoprecipitation of TXNIP–STAT3, Txnip-KO mice, TXNIP overexpression in tubular cells, STAT3 inhibitor epistasis","journal":"Mechanisms of ageing and development","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus genetic KO and pharmacological epistasis; single lab","pmids":["33781783"],"is_preprint":false},{"year":2021,"finding":"TXNIP contains two C-terminal PPXY motifs that mediate E3 ubiquitin ligase binding; TRAF6 ubiquitylates TXNIP via TRAF6 Cys70-dependent mechanisms, and TXNIP interacts with TRAF6 through its PPxY motif. Sodium butyrate reinforces TRAF6/TXNIP interaction and polyubiquitylation of TXNIP.","method":"Co-immunoprecipitation, ubiquitylation assays with TRAF6 C70A mutant, PPxY motif mutant analysis, siRNA knockdown","journal":"Cancer medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP and ubiquitylation assays with mutational analysis; single lab","pmids":["31578830"],"is_preprint":false},{"year":2021,"finding":"AAV-delivered Txnip prolongs cone photoreceptor survival in retinitis pigmentosa mouse models; the C247S allele (which cannot bind thioredoxin) provides greater rescue than WT Txnip, and the rescue depends on lactate dehydrogenase b (Ldhb), implicating enhanced lactate catabolism as the mechanism by which TXNIP supports cone survival.","method":"AAV gene delivery, RP mouse models, C247S allele comparison, Ldhb genetic epistasis, visual acuity testing, mitochondrial health imaging","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic rescue with epistasis (Ldhb KO abrogates effect); C247S allele comparison establishes TRX-independent mechanism","pmids":["33847261"],"is_preprint":false},{"year":2022,"finding":"TXNIP shuttles between different subcellular compartments—primarily nucleus under basal conditions and mitochondria under oxidative/ER stress—functioning as a gatekeeper of Trx1 (cytosol) and Trx2 (mitochondria) depending on localization; mitochondrial TXNIP promotes ROS accumulation via Trx2 oxidation, releasing ASK1 to activate apoptosis.","method":"Subcellular fractionation, immunofluorescence live-cell imaging, Chop−/− and Txnip−/− mice, mitochondrial ROS probe (68Ga-Galuminox), Co-IP","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — fractionation, imaging, and genetic KO mice with in vivo molecular imaging; multiple orthogonal approaches","pmids":["35994650"],"is_preprint":false},{"year":2023,"finding":"NEDD4L E3 ubiquitin ligase ubiquitinates TXNIP, targeting it for degradation; in NASH, decreased NEDD4L causes TXNIP protein accumulation. Accumulated TXNIP binds the N-terminus of the α-helix domain of CHOP and reduces CHOP ubiquitination, thereby increasing CHOP protein stability and promoting ER stress-mediated apoptosis in hepatocytes.","method":"Co-IP of TXNIP–CHOP domain mapping, ubiquitination assays, four NASH mouse models, adenoviral shRNA liver-specific knockdown, gain-/loss-of-function","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 2 — Co-IP with domain mapping, ubiquitination assays, and multiple in vivo models; mechanistically comprehensive","pmids":["37153733"],"is_preprint":false},{"year":2016,"finding":"BioID proximity labeling identified 31 TXNIP-interacting proteins; many interactions are redox-dependent and disrupted by the C247S mutation (loss of thioredoxin binding), and hyperglycemia dynamically alters the TXNIP interactome, providing a molecular basis for its pleiotropic functions.","method":"BioID proximity labeling followed by mass spectrometry, C247S mutant comparison, hyperglycemia treatment","journal":"Oxidative medicine and cellular longevity","confidence":"Medium","confidence_rationale":"Tier 2 — proximity-labeling MS interactome with redox-dependent and glucose-dependent validation; single lab","pmids":["27437069"],"is_preprint":false},{"year":2021,"finding":"TXNIP positively regulates autophagy in retinal Müller cells under high glucose by inhibiting the PI3K/AKT/mTOR signaling pathway; CRISPR/Cas9 knockout of TXNIP reduces autophagy and apoptosis under high glucose and improves visual response in diabetic retinopathy.","method":"CRISPR/Cas9 KO, overexpression, PI3K/AKT/mTOR phosphorylation western blot, electroretinogram","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2–3 — CRISPR KO plus overexpression with pathway analysis and in vivo functional readout; single lab","pmids":["33412212"],"is_preprint":false},{"year":2022,"finding":"TXNIP suppresses osteochondrogenic differentiation of vascular smooth muscle cells (VSMCs) by inhibiting BMP signaling; smooth muscle cell-specific Txnip deletion (Tagln-Cre; Txnipflox/flox) recapitulates increased atherosclerotic calcification, and BMP inhibitor K02288 abrogates the pro-osteogenic effect of TXNIP suppression in cultured VSMCs.","method":"Conditional VSMC-specific KO mice, single-cell RNA-seq, primary VSMC culture, BMP inhibitor epistasis (K02288)","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with scRNA-seq and pharmacological epistasis confirming BMP pathway as mechanistic effector","pmids":["36448450"],"is_preprint":false},{"year":2019,"finding":"UHRF1 recruits HDAC1 to the TXNIP promoter and mediates deacetylation of histone H3K9, resulting in transcriptional silencing of TXNIP in renal cell carcinoma; UHRF1 knockdown de-represses TXNIP, and simultaneous TXNIP knockdown rescues the anti-tumor effects of UHRF1 depletion.","method":"ChIP for HDAC1 at TXNIP promoter, H3K9 acetylation ChIP, siRNA/shRNA double knockdown, xenograft tumor model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrating epigenetic mechanism, epistasis rescue experiment, and in vivo xenograft validation","pmids":["31043707"],"is_preprint":false},{"year":2022,"finding":"SIRT6 transcriptionally represses TXNIP by deacetylating H3K9ac and H3K56ac at the TXNIP promoter in microglia and brain microvascular endothelial cells; this SIRT6-mediated TXNIP suppression mediates the protective effects of energy restriction/intermittent fasting on cerebral ischemia.","method":"ChIP for H3K9ac and H3K56ac at TXNIP promoter, SIRT6 overexpression, OGD/R cell model, MCAO mouse model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-confirmed histone deacetylation at TXNIP locus with functional rescue; single lab","pmids":["35562171"],"is_preprint":false},{"year":2023,"finding":"USP5 deubiquitylase interacts with TXNIP (demonstrated by Co-IP) and stabilizes TXNIP protein through deubiquitylation, promoting LPS-induced apoptosis and NLRP3 inflammasome activation; USP5 knockdown reduces TXNIP levels and is reversed by TXNIP overexpression.","method":"Deubiquitylase overexpression screen, Co-immunoprecipitation, ubiquitylation assays, siRNA knockdown, epistasis rescue","journal":"Hepatology communications","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP and ubiquitylation assay identifying USP5 as deubiquitylase; single lab with functional validation","pmids":["37534934"],"is_preprint":false},{"year":2021,"finding":"TXNIP mRNA is directly regulated by MondoA (not ChREBP) in cervical cancer cells; MondoA overexpression inhibits cell proliferation, migration, and invasion through upregulating TXNIP, placing MondoA as the upstream transcriptional inducer of TXNIP in a cell-type-dependent manner.","method":"MondoA/ChREBP overexpression, TXNIP reporter assay, siRNA knockdown, migration/invasion assays","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — reporter assays and epistasis rescue identifying transcription factor specificity; single lab","pmids":["31782782"],"is_preprint":false},{"year":2025,"finding":"Lactic acid in the tumor microenvironment activates the MondoA–TXNIP transcriptional axis in CD8+ T cells and Tregs via SENP1-mediated de-SUMOylation of MondoA; TXNIP induction impairs TCR/CD28-signal-induced CD8+ T cell activation by restricting glucose uptake; MondoA-deficient Tregs lose immunosuppressive capacity while MondoA-deficient CD8+ T cells show enhanced cytotoxicity.","method":"MondoA conditional KO mice, SENP1 manipulation, glucose uptake assays, TCR/CD28 signaling assays, tumor models with anti-PD-1 combination, TXNIP ChIP","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 2 — genetic KO in specific immune subsets, mechanistic identification of SENP1/SUMOylation upstream of MondoA-TXNIP, and functional in vivo tumor immunology validation","pmids":["40846790"],"is_preprint":false}],"current_model":"TXNIP is a multifunctional α-arrestin scaffold protein that primarily inhibits thioredoxin (TRX) by direct disulfide-dependent binding (requiring TRX Cys32/Cys35 and TXNIP Cys247), and additionally shuttles between the nucleus (basal), cytoplasm, and mitochondria depending on redox/ER stress to regulate GLUT1/glucose uptake (via C-ARR domain interaction and LL-motif-driven lysosomal degradation), activate the NLRP3 inflammasome (interaction stabilized by O-GlcNAcylation), promote apoptosis through mitochondrial Trx2-ASK1 release, stabilize p27(kip1) by blocking JAB1, mediate HIF1α nuclear export via pVHL, and suppress BMP signaling in vascular smooth muscle cells; its expression is transcriptionally driven by glucose/MondoA/ChREBP through a carbohydrate response element, induced by glucocorticoid receptor, epigenetically regulated by histone acetylation and SIRT6-mediated deacetylation, and post-translationally controlled by NEDD4L-mediated ubiquitination (degradation) and USP5-mediated deubiquitination (stabilization) as well as thioredoxin-binding-dependent proteasomal protection."},"narrative":{"teleology":[{"year":2000,"claim":"The foundational question of whether TXNIP directly binds thioredoxin was resolved: TXNIP interacts with TRX through a region spanning aa 155–225, requiring the TRX active-site cysteines Cys32/Cys35, establishing TXNIP as the first endogenous TRX inhibitor.","evidence":"Yeast two-hybrid screen with deletion and cysteine-to-serine point mutagenesis","pmids":["10814541"],"confidence":"High","gaps":["TXNIP's own cysteine residue mediating the disulfide bond was not yet identified","functional consequences of TRX inhibition in vivo were not addressed"]},{"year":2005,"claim":"Beyond redox regulation, TXNIP was shown to control cell proliferation by binding JAB1 and preventing JAB1-mediated cytoplasmic translocation and degradation of the CDK inhibitor p27(kip1), revealing a TRX-independent tumor-suppressive mechanism.","evidence":"Reciprocal Co-IP, VDUP1−/− fibroblast phenotyping, nuclear export rescue assay","pmids":["15930262"],"confidence":"High","gaps":["Whether the JAB1 interaction depends on the same domain as TRX binding was unknown","relevance to in vivo tumor suppression was not tested"]},{"year":2006,"claim":"Two parallel advances defined TXNIP's role as a nuclear scaffold and its transcriptional regulation: TXNIP was found to bridge pVHL and HIF1α for CRM1-dependent nuclear export and degradation of HIF1α, and glucocorticoid receptor was identified as a direct transcriptional inducer of TXNIP through a GRE in its promoter, with TXNIP mediating GR-induced apoptosis.","evidence":"Co-IP with NES mutagenesis and leptomycin B rescue for pVHL–HIF1α axis; promoter deletion/mutation reporter assays and RNAi rescue for GR–apoptosis axis","pmids":["18062927","16301999"],"confidence":"High","gaps":["Whether the pVHL and TRX interactions are mutually exclusive was not determined","identity of TXNIP's NES and its regulation were not fully mapped"]},{"year":2009,"claim":"The glucose-sensing transcriptional mechanism was elucidated: MondoA and Mlx were identified as the transcription factors that induce TXNIP through a carbohydrate response element (ChoRE) in the promoter, explaining how TXNIP expression tracks cellular glucose availability.","evidence":"Promoter reporter assays with MondoA/ChREBP overexpression and adenosine analog treatment","pmids":["19246513"],"confidence":"Medium","gaps":["Cell-type specificity of MondoA versus ChREBP contribution was unresolved","chromatin-level confirmation (e.g., ChIP) was not performed in this study"]},{"year":2011,"claim":"The reciprocal stabilization between TXNIP and TRX was demonstrated: TRX binding protects TXNIP from proteasomal degradation via PPXY-motif-dependent E3 ligase recruitment, and TXNIP Cys247 was identified as essential for the disulfide bond; separately, hypothalamic TXNIP was shown to regulate systemic metabolism, as MBH-specific knockdown prevented diet-induced obesity.","evidence":"C247S and PPXY mutagenesis with proteasome inhibitor and adipogenesis assays; lentiviral shRNA in mouse MBH with metabolic phenotyping","pmids":["21705327","21508227"],"confidence":"High","gaps":["The specific E3 ligase recognizing the PPXY motifs was not identified at this stage","the TRX-independent metabolic functions in neurons were not mechanistically dissected"]},{"year":2012,"claim":"Cell-type-specific genetic manipulation in Agrp neurons demonstrated that TXNIP bidirectionally controls energy expenditure and diet-induced obesity through central leptin sensitivity, independent of food intake.","evidence":"Agrp-Ires-Cre × Txnip-flox conditional KO and lentiviral gain-of-function with metabolic cage phenotyping","pmids":["22815502"],"confidence":"High","gaps":["Direct molecular target of TXNIP in Agrp neurons (beyond leptin sensitivity) was not defined","whether TRX inhibition or GLUT regulation mediates the neuronal effect was unknown"]},{"year":2015,"claim":"Upstream signaling inputs to TXNIP were expanded: CD36 was placed upstream of NF-κB-dependent TXNIP induction in β-cells during ceramide stress, and PPARδ was identified as a mediator of 4-HNE-induced TXNIP upregulation driving endothelial senescence.","evidence":"SSO pharmacological blockade with NF-κB inhibition epistasis in INS-1 cells; co-culture transwell system with PPARδ modulation and senescence assays","pmids":["26297980","25754218"],"confidence":"Medium","gaps":["Direct promoter binding by NF-κB at the TXNIP locus was not confirmed by ChIP","whether PPARδ directly binds the TXNIP promoter or acts indirectly was unclear"]},{"year":2016,"claim":"Three mechanistic dimensions were clarified: (1) glucose-driven histone acetylation (H3K9ac, H3K4me3) at the TXNIP promoter was established as an epigenetic mechanism of TXNIP induction; (2) the C-terminal arrestin domain and di-leucine motif were mapped as the structural basis for GLUT1 endocytosis and lysosomal degradation; (3) BioID proximity labeling revealed a redox-dependent interactome of 31 partners altered by C247S mutation and hyperglycemia.","evidence":"ChIP with p300 inhibitor C646 in diabetic kidneys; C-ARR domain deletion and LL motif mutagenesis with glucose uptake assays; BioID-MS with C247S comparison","pmids":["26806835","38329960","27437069"],"confidence":"High","gaps":["Which specific histone acetyltransferases other than p300 contribute was not resolved","whether the 31 BioID-identified interactors represent direct or proximity-based associations was unclear"]},{"year":2018,"claim":"Two modes of TXNIP regulation were defined: ZFP36 was identified as an mRNA decay factor that degrades TXNIP transcripts downstream of receptor tyrosine kinase signaling to permit GLUT1 surface enrichment and glycolysis; separately, Ras was shown to suppress TXNIP at the translational elongation level through a mechanism dependent on the N-terminal nascent polypeptide.","evidence":"Unbiased glycolytic driver screen with ZFP36 mRNA decay assays and GLUT1 surface quantification; polysome profiling and ribosome transit assays with codon optimization mutagenesis","pmids":["30197082","30037981"],"confidence":"High","gaps":["The RNA-binding protein or ribosome factor mediating Ras-dependent translational stalling was not identified","whether ZFP36 and Ras pathways converge was not tested"]},{"year":2019,"claim":"O-GlcNAcylation was identified as a post-translational modification that stabilizes the TXNIP–NLRP3 interaction in pancreatic β-cells, with UHRF1/HDAC1-mediated H3K9 deacetylation separately established as an epigenetic silencing mechanism for TXNIP in renal cell carcinoma.","evidence":"O-GlcNAc immunoprecipitation with OGT/OGA manipulation and IL-1β ELISA in human islets; ChIP for HDAC1 at TXNIP promoter with epistasis knockdown and xenograft validation","pmids":["31164864","31043707"],"confidence":"High","gaps":["The specific O-GlcNAcylation sites on TXNIP were not mapped","whether UHRF1-mediated silencing operates in non-cancer contexts was not tested"]},{"year":2020,"claim":"TXNIP was shown to directly bind and activate AMPKα, leading to mTORC1 inactivation and TFEB nuclear translocation to promote autophagy and fatty acid oxidation in hepatocytes; Txnip-KO mice developed exacerbated steatohepatitis.","evidence":"Co-IP of TXNIP–PRKAA, Txnip-KO mice on MCD diet, rapamycin rescue, Atg7 siRNA epistasis","pmids":["33190588"],"confidence":"High","gaps":["Whether TXNIP activates AMPK through allosteric binding or by affecting upstream kinases was not resolved","the interplay between TRX inhibition and AMPK activation was not dissected"]},{"year":2021,"claim":"Multiple new regulatory connections were established: AAV-delivered TXNIP C247S (TRX-binding-deficient) rescued cone photoreceptors in retinitis pigmentosa models via Ldhb-dependent lactate catabolism; TXNIP was found to bind STAT3 and promote renal fibrosis/senescence; TRAF6 was identified as a ubiquitin ligase for TXNIP via its PPXY motifs; and MondoA (not ChREBP) was confirmed as the cell-type-specific transcriptional inducer in cervical cancer.","evidence":"AAV gene delivery with C247S allele and Ldhb epistasis in RP mice; Co-IP of TXNIP–STAT3 with Txnip-KO mice; Co-IP and ubiquitylation assays with TRAF6 C70A mutant; MondoA reporter assays and siRNA epistasis","pmids":["33847261","33781783","31578830","31782782"],"confidence":"High","gaps":["Whether TXNIP's lactate-catabolism-promoting activity operates in tissues other than photoreceptors was unknown","the STAT3 binding interface on TXNIP was not mapped","whether TRAF6 is the physiological E3 ligase in metabolic tissues was not confirmed"]},{"year":2022,"claim":"The stress-dependent subcellular trafficking of TXNIP was defined: TXNIP resides in the nucleus basally but shuttles to mitochondria under oxidative/ER stress (CHOP-dependent), where it displaces ASK1 from Trx2 to trigger apoptosis and engages NLRP3 for inflammasome activation; SIRT6 was identified as a TXNIP transcriptional repressor via H3K9ac/H3K56ac deacetylation; and VSMC-specific Txnip deletion increased atherosclerotic calcification through de-repressed BMP signaling.","evidence":"Subcellular fractionation with Chop−/− and Txnip−/− mice and 68Ga-Galuminox imaging; ChIP for H3K9ac/H3K56ac with SIRT6 overexpression; Tagln-Cre Txnipflox/flox mice with scRNA-seq and BMP inhibitor epistasis","pmids":["35994650","35562171","36448450"],"confidence":"High","gaps":["The signal or kinase mediating CHOP-dependent TXNIP phosphorylation/mitochondrial import was not identified","whether SIRT6 regulation is tissue-specific or generalizable was not addressed"]},{"year":2023,"claim":"The E3 ligase NEDD4L was identified as the primary ubiquitin ligase targeting TXNIP for degradation in NASH; accumulated TXNIP reciprocally stabilizes CHOP by binding its N-terminal α-helix domain and reducing CHOP ubiquitination. Separately, USP5 was identified as a deubiquitylase that stabilizes TXNIP to promote NLRP3 inflammasome activation.","evidence":"Co-IP with TXNIP–CHOP domain mapping and ubiquitination assays in four NASH mouse models; deubiquitylase screen with Co-IP and epistasis rescue","pmids":["37153733","37534934"],"confidence":"High","gaps":["Whether NEDD4L and USP5 compete for TXNIP regulation in the same cellular context was not tested","the ubiquitin chain type on TXNIP was not fully characterized"]},{"year":2025,"claim":"The MondoA–TXNIP axis was shown to operate as a metabolic checkpoint in tumor immunity: lactic acid activates MondoA via SENP1-mediated de-SUMOylation, inducing TXNIP in CD8+ T cells to restrict glucose uptake and impair TCR/CD28 signaling, while the same axis maintains Treg immunosuppressive function.","evidence":"MondoA conditional KO mice in immune subsets, SENP1 manipulation, glucose uptake and TCR signaling assays, tumor models with anti-PD-1","pmids":["40846790"],"confidence":"High","gaps":["Whether direct TXNIP–GLUT1 interaction mediates T cell glucose restriction or an alternative mechanism operates was not confirmed","the TXNIP O-GlcNAcylation and inflammasome axis in the tumor immune microenvironment was not integrated"]},{"year":null,"claim":"Key unresolved questions include the structural basis of TXNIP's multi-domain scaffold interactions (no crystal or cryo-EM structure of TXNIP in complex with any partner), the identity of the kinase or signal mediating CHOP-dependent TXNIP phosphorylation and mitochondrial import, and how competing post-translational modifications (O-GlcNAcylation, ubiquitination by NEDD4L/TRAF6, deubiquitination by USP5, TRX-mediated stabilization) are coordinately regulated in different tissues.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of TXNIP or its complexes exists","The specific phosphorylation sites driving mitochondrial translocation are unmapped","Tissue-specific hierarchy of TXNIP's E3 ligases (NEDD4L vs TRAF6) and deubiquitylases is unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,9,11,24]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,9,10]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,20]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[10,20]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,9]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,10,20]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[8,9,19]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[11,23]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[3,10,20]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[13,29]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[4,21,27]}],"complexes":["NLRP3 inflammasome"],"partners":["TXN","TXN2","NLRP3","GLUT1","JAB1","PRKAA1","NEDD4L","USP5"],"other_free_text":[]},"mechanistic_narrative":"TXNIP is a multifunctional α-arrestin scaffold protein that serves as a central integrator of cellular redox sensing, glucose metabolism, and stress-induced signaling. It directly binds and inhibits thioredoxin (TRX) via a disulfide bond requiring TRX Cys32/Cys35 and TXNIP Cys247, and this interaction reciprocally stabilizes TXNIP protein against proteasomal degradation [PMID:10814541, PMID:21705327]; TXNIP also suppresses glucose uptake by promoting GLUT1 internalization and lysosomal degradation through its C-terminal arrestin domain and a di-leucine endocytic motif [PMID:38329960, PMID:30197082]. Under ER/oxidative stress, TXNIP shuttles from the nucleus to mitochondria where it displaces ASK1 from Trx2 to trigger apoptosis and activates the NLRP3 inflammasome—an interaction enhanced by O-GlcNAcylation—while also regulating autophagy via AMPK activation and mTORC1 inhibition [PMID:35994650, PMID:31164864, PMID:33190588]. TXNIP expression is transcriptionally driven by glucose through the MondoA/ChREBP–ChoRE axis and by glucocorticoid receptor signaling, epigenetically tuned by histone acetylation at its promoter, and post-translationally controlled by NEDD4L-mediated ubiquitination and USP5-mediated deubiquitination [PMID:19246513, PMID:16301999, PMID:26806835, PMID:37153733, PMID:37534934]."},"prefetch_data":{"uniprot":{"accession":"Q9H3M7","full_name":"Thioredoxin-interacting protein","aliases":["Thioredoxin-binding protein 2","Vitamin D3 up-regulated protein 1"],"length_aa":391,"mass_kda":43.7,"function":"May act as an oxidative stress mediator by inhibiting thioredoxin activity or by limiting its bioavailability (PubMed:17603038). Interacts with COPS5 and restores COPS5-induced suppression of CDKN1B stability, blocking the COPS5-mediated translocation of CDKN1B from the nucleus to the cytoplasm (By similarity). Functions as a transcriptional repressor, possibly by acting as a bridge molecule between transcription factors and corepressor complexes, and over-expression will induce G0/G1 cell cycle arrest (PubMed:12821938). Required for the maturation of natural killer cells (By similarity). Acts as a suppressor of tumor cell growth (PubMed:18541147). Inhibits the proteasomal degradation of DDIT4, and thereby contributes to the inhibition of the mammalian target of rapamycin complex 1 (mTORC1) (PubMed:21460850)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9H3M7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TXNIP","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TXNIP","total_profiled":1310},"omim":[{"mim_id":"616464","title":"ECDYSONELESS CELL CYCLE REGULATOR; ECD","url":"https://www.omim.org/entry/616464"},{"mim_id":"613065","title":"LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL","url":"https://www.omim.org/entry/613065"},{"mim_id":"612464","title":"ARRESTIN DOMAIN-CONTAINING PROTEIN 3; ARRDC3","url":"https://www.omim.org/entry/612464"},{"mim_id":"606599","title":"THIOREDOXIN-INTERACTING PROTEIN; TXNIP","url":"https://www.omim.org/entry/606599"},{"mim_id":"603023","title":"IKAROS FAMILY ZINC FINGER 1; IKZF1","url":"https://www.omim.org/entry/603023"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TXNIP"},"hgnc":{"alias_symbol":["VDUP1","EST01027","HHCPA78","THIF","ARRDC6"],"prev_symbol":[]},"alphafold":{"accession":"Q9H3M7","domains":[{"cath_id":"2.60.40.640","chopping":"6-144","consensus_level":"high","plddt":87.595,"start":6,"end":144},{"cath_id":"2.60.40.640","chopping":"153-295","consensus_level":"high","plddt":90.7945,"start":153,"end":295}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H3M7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H3M7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H3M7-F1-predicted_aligned_error_v6.png","plddt_mean":78.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TXNIP","jax_strain_url":"https://www.jax.org/strain/search?query=TXNIP"},"sequence":{"accession":"Q9H3M7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H3M7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H3M7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H3M7"}},"corpus_meta":[{"pmid":"37394581","id":"PMC_37394581","title":"TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target.","date":"2023","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37394581","citation_count":238,"is_preprint":false},{"pmid":"30197082","id":"PMC_30197082","title":"Extracellular Matrix Remodeling Regulates Glucose Metabolism through TXNIP Destabilization.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/30197082","citation_count":211,"is_preprint":false},{"pmid":"33190588","id":"PMC_33190588","title":"TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/33190588","citation_count":179,"is_preprint":false},{"pmid":"28137209","id":"PMC_28137209","title":"TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook.","date":"2017","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/28137209","citation_count":174,"is_preprint":false},{"pmid":"22750447","id":"PMC_22750447","title":"Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer.","date":"2012","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/22750447","citation_count":147,"is_preprint":false},{"pmid":"16607285","id":"PMC_16607285","title":"Hepatocellular carcinoma in Txnip-deficient mice.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16607285","citation_count":131,"is_preprint":false},{"pmid":"15930262","id":"PMC_15930262","title":"Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15930262","citation_count":123,"is_preprint":false},{"pmid":"33425493","id":"PMC_33425493","title":"circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/33425493","citation_count":120,"is_preprint":false},{"pmid":"33302545","id":"PMC_33302545","title":"Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33302545","citation_count":117,"is_preprint":false},{"pmid":"24353900","id":"PMC_24353900","title":"Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy.","date":"2013","source":"Journal of clinical & experimental ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/24353900","citation_count":109,"is_preprint":false},{"pmid":"10814541","id":"PMC_10814541","title":"A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10814541","citation_count":105,"is_preprint":false},{"pmid":"17976314","id":"PMC_17976314","title":"Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases.","date":"2007","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17976314","citation_count":98,"is_preprint":false},{"pmid":"16301999","id":"PMC_16301999","title":"Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16301999","citation_count":98,"is_preprint":false},{"pmid":"30741672","id":"PMC_30741672","title":"Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer's Disease Brain.","date":"2019","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/30741672","citation_count":95,"is_preprint":false},{"pmid":"35450411","id":"PMC_35450411","title":"TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/35450411","citation_count":93,"is_preprint":false},{"pmid":"16388576","id":"PMC_16388576","title":"Structure of the Escherichia coli ThiS-ThiF complex, a key component of the sulfur transfer system in thiamin biosynthesis.","date":"2006","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16388576","citation_count":92,"is_preprint":false},{"pmid":"29356688","id":"PMC_29356688","title":"Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.","date":"2018","source":"Current opinion in endocrinology, diabetes, and obesity","url":"https://pubmed.ncbi.nlm.nih.gov/29356688","citation_count":87,"is_preprint":false},{"pmid":"24645981","id":"PMC_24645981","title":"Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer.","date":"2014","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24645981","citation_count":87,"is_preprint":false},{"pmid":"26806835","id":"PMC_26806835","title":"Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney.","date":"2016","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/26806835","citation_count":85,"is_preprint":false},{"pmid":"36299604","id":"PMC_36299604","title":"Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/36299604","citation_count":76,"is_preprint":false},{"pmid":"33323975","id":"PMC_33323975","title":"C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/33323975","citation_count":74,"is_preprint":false},{"pmid":"33412212","id":"PMC_33412212","title":"TXNIP positively regulates the autophagy and apoptosis in the rat müller cell of diabetic retinopathy.","date":"2021","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33412212","citation_count":68,"is_preprint":false},{"pmid":"31173172","id":"PMC_31173172","title":"Role of TXNIP/NLRP3 in sepsis-induced myocardial dysfunction.","date":"2019","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31173172","citation_count":63,"is_preprint":false},{"pmid":"18062927","id":"PMC_18062927","title":"VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18062927","citation_count":62,"is_preprint":false},{"pmid":"17040494","id":"PMC_17040494","title":"Vitamin D3 upregulated protein 1 (VDUP1) is a regulator for redox signaling and stress-mediated diseases.","date":"2006","source":"The Journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/17040494","citation_count":61,"is_preprint":false},{"pmid":"37794178","id":"PMC_37794178","title":"The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control.","date":"2023","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37794178","citation_count":58,"is_preprint":false},{"pmid":"29339473","id":"PMC_29339473","title":"Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29339473","citation_count":56,"is_preprint":false},{"pmid":"25754218","id":"PMC_25754218","title":"Foam cell-derived 4-hydroxynonenal induces endothelial cell senescence in a TXNIP-dependent manner.","date":"2015","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25754218","citation_count":53,"is_preprint":false},{"pmid":"15896804","id":"PMC_15896804","title":"Structural analysis of Escherichia coli ThiF.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15896804","citation_count":51,"is_preprint":false},{"pmid":"31615975","id":"PMC_31615975","title":"Oxidative stress-mediated TXNIP loss causes RPE dysfunction.","date":"2019","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31615975","citation_count":50,"is_preprint":false},{"pmid":"31043707","id":"PMC_31043707","title":"UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31043707","citation_count":50,"is_preprint":false},{"pmid":"35994650","id":"PMC_35994650","title":"Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35994650","citation_count":50,"is_preprint":false},{"pmid":"21508227","id":"PMC_21508227","title":"Nutrient-sensing hypothalamic TXNIP links nutrient excess to energy imbalance in mice.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21508227","citation_count":49,"is_preprint":false},{"pmid":"33567593","id":"PMC_33567593","title":"The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33567593","citation_count":49,"is_preprint":false},{"pmid":"36881408","id":"PMC_36881408","title":"SIRT1 Inhibits High Glucose-Induced TXNIP/NLRP3 Inflammasome Activation and Cataract Formation.","date":"2023","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/36881408","citation_count":48,"is_preprint":false},{"pmid":"21705327","id":"PMC_21705327","title":"Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21705327","citation_count":48,"is_preprint":false},{"pmid":"11376942","id":"PMC_11376942","title":"Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11376942","citation_count":47,"is_preprint":false},{"pmid":"36448450","id":"PMC_36448450","title":"TXNIP Suppresses the Osteochondrogenic Switch of Vascular Smooth Muscle Cells in Atherosclerosis.","date":"2022","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/36448450","citation_count":43,"is_preprint":false},{"pmid":"35562171","id":"PMC_35562171","title":"Energy restriction induced SIRT6 inhibits microglia activation and promotes angiogenesis in cerebral ischemia via transcriptional inhibition of TXNIP.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35562171","citation_count":40,"is_preprint":false},{"pmid":"11579135","id":"PMC_11579135","title":"Rapid induction and Ca(2+) influx-mediated suppression of vitamin D3 up-regulated protein 1 (VDUP1) mRNA in cerebellar granule neurons undergoing apoptosis.","date":"2001","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11579135","citation_count":40,"is_preprint":false},{"pmid":"22815502","id":"PMC_22815502","title":"TXNIP in Agrp neurons regulates adiposity, energy expenditure, and central leptin sensitivity.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22815502","citation_count":39,"is_preprint":false},{"pmid":"19246513","id":"PMC_19246513","title":"Adenosine-containing molecules amplify glucose signaling and enhance txnip expression.","date":"2009","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19246513","citation_count":38,"is_preprint":false},{"pmid":"37525261","id":"PMC_37525261","title":"Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1α-TXNIP/ROS-NLRP3 pathway in PCOS.","date":"2023","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/37525261","citation_count":37,"is_preprint":false},{"pmid":"34350508","id":"PMC_34350508","title":"Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols.","date":"2021","source":"Inflammopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34350508","citation_count":37,"is_preprint":false},{"pmid":"33847261","id":"PMC_33847261","title":"AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33847261","citation_count":36,"is_preprint":false},{"pmid":"33716060","id":"PMC_33716060","title":"Ligustrazine alleviates cyclophosphamide-induced hepatotoxicity via the inhibition of Txnip/Trx/NF-κB pathway.","date":"2021","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33716060","citation_count":34,"is_preprint":false},{"pmid":"39117021","id":"PMC_39117021","title":"Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome.","date":"2024","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39117021","citation_count":33,"is_preprint":false},{"pmid":"32639616","id":"PMC_32639616","title":"Thioredoxin interacting protein (TXNIP) acts as a tumor suppressor in human prostate cancer.","date":"2020","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/32639616","citation_count":31,"is_preprint":false},{"pmid":"33612104","id":"PMC_33612104","title":"Role of ASM/Cer/TXNIP signaling module in the NLRP3 inflammasome activation.","date":"2021","source":"Lipids in health and disease","url":"https://pubmed.ncbi.nlm.nih.gov/33612104","citation_count":30,"is_preprint":false},{"pmid":"28871193","id":"PMC_28871193","title":"Estradiol Regulates Txnip and Prevents Intermittent Hypoxia-Induced Vascular Injury.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28871193","citation_count":30,"is_preprint":false},{"pmid":"37689128","id":"PMC_37689128","title":"PIAS3 promotes ferroptosis by regulating TXNIP via TGF-β signaling pathway in hepatocellular carcinoma.","date":"2023","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/37689128","citation_count":29,"is_preprint":false},{"pmid":"36271546","id":"PMC_36271546","title":"Calycosin modulates NLRP3 and TXNIP-mediated pyroptotic signaling and attenuates diabetic nephropathy progression in diabetic rats; An insight.","date":"2022","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/36271546","citation_count":28,"is_preprint":false},{"pmid":"31578830","id":"PMC_31578830","title":"Sodium butyrate-activated TRAF6-TXNIP pathway affects A549 cells proliferation and migration.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31578830","citation_count":26,"is_preprint":false},{"pmid":"34461109","id":"PMC_34461109","title":"HOXA9-induced chemerin signals through CMKLR1/AMPK/TXNIP/NLRP3 pathway to induce pyroptosis of trophoblasts and aggravate preeclampsia.","date":"2021","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34461109","citation_count":26,"is_preprint":false},{"pmid":"31931042","id":"PMC_31931042","title":"Estrogen protects neuroblastoma cell from amyloid-β 42 (Aβ42)-induced apoptosis via TXNIP/TRX axis and AMPK signaling.","date":"2020","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/31931042","citation_count":24,"is_preprint":false},{"pmid":"32164364","id":"PMC_32164364","title":"Silibinin Attenuates Silica Dioxide Nanoparticles-Induced Inflammation by Suppressing TXNIP/MAPKs/AP-1 Signaling.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32164364","citation_count":24,"is_preprint":false},{"pmid":"38890620","id":"PMC_38890620","title":"Circ6834 suppresses non-small cell lung cancer progression by destabilizing ANHAK and regulating miR-873-5p/TXNIP axis.","date":"2024","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38890620","citation_count":23,"is_preprint":false},{"pmid":"31782782","id":"PMC_31782782","title":"TXNIP induced by MondoA, rather than ChREBP, suppresses cervical cancer cell proliferation, migration and invasion.","date":"2020","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31782782","citation_count":23,"is_preprint":false},{"pmid":"34614512","id":"PMC_34614512","title":"TXNIP Links Anticipatory Unfolded Protein Response to Estrogen Reprogramming Glucose Metabolism in Breast Cancer Cells.","date":"2022","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34614512","citation_count":22,"is_preprint":false},{"pmid":"37116352","id":"PMC_37116352","title":"Memantine mitigates ROS/TXNIP/NLRP3 signaling and protects against mouse diabetic retinopathy: Histopathologic, ultrastructural and bioinformatic studies.","date":"2023","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/37116352","citation_count":22,"is_preprint":false},{"pmid":"36251276","id":"PMC_36251276","title":"Ferulic acid relieved ulcerative colitis by inhibiting the TXNIP/NLRP3 pathway in rats.","date":"2022","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/36251276","citation_count":22,"is_preprint":false},{"pmid":"31900750","id":"PMC_31900750","title":"Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation.","date":"2020","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31900750","citation_count":22,"is_preprint":false},{"pmid":"38329960","id":"PMC_38329960","title":"TXNIP-mediated crosstalk between oxidative stress and glucose metabolism.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/38329960","citation_count":21,"is_preprint":false},{"pmid":"33781783","id":"PMC_33781783","title":"Role and mechanism of TXNIP in ageing-related renal fibrosis.","date":"2021","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/33781783","citation_count":21,"is_preprint":false},{"pmid":"33638792","id":"PMC_33638792","title":"Long Non-coding RNA GAS5 Worsens Coronary Atherosclerosis Through MicroRNA-194-3p/TXNIP Axis.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/33638792","citation_count":21,"is_preprint":false},{"pmid":"36828294","id":"PMC_36828294","title":"ChREBP-β/TXNIP aggravates frucose-induced renal injury through triggering ferroptosis of renal tubular epithelial cells.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36828294","citation_count":20,"is_preprint":false},{"pmid":"34804174","id":"PMC_34804174","title":"Luteolin Improves Cyclophosphamide-Induced Cystitis through TXNIP/NLRP3 and NF-κB Pathways.","date":"2021","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/34804174","citation_count":20,"is_preprint":false},{"pmid":"26154105","id":"PMC_26154105","title":"A novel TXNIP-based mechanism for Cx43-mediated regulation of oxidative drug injury.","date":"2015","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26154105","citation_count":20,"is_preprint":false},{"pmid":"26297980","id":"PMC_26297980","title":"CD36 initiated signaling mediates ceramide-induced TXNIP expression in pancreatic beta-cells.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26297980","citation_count":20,"is_preprint":false},{"pmid":"33748706","id":"PMC_33748706","title":"Dual regulation of TxNIP by ChREBP and FoxO1 in liver.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/33748706","citation_count":19,"is_preprint":false},{"pmid":"31164864","id":"PMC_31164864","title":"O-GlcNacylation Links TxNIP to Inflammasome Activation in Pancreatic β Cells.","date":"2019","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31164864","citation_count":19,"is_preprint":false},{"pmid":"37153733","id":"PMC_37153733","title":"A novel NEDD4L-TXNIP-CHOP axis in the pathogenesis of nonalcoholic steatohepatitis.","date":"2023","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/37153733","citation_count":18,"is_preprint":false},{"pmid":"36603341","id":"PMC_36603341","title":"Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36603341","citation_count":18,"is_preprint":false},{"pmid":"38896955","id":"PMC_38896955","title":"The ROS/TXNIP/NLRP3 pathway mediates LPS-induced microglial inflammatory response.","date":"2024","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/38896955","citation_count":17,"is_preprint":false},{"pmid":"39102928","id":"PMC_39102928","title":"piR112710 attenuates diabetic cardiomyopathy through inhibiting Txnip/NLRP3-mediated pyroptosis in db/db mice.","date":"2024","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/39102928","citation_count":17,"is_preprint":false},{"pmid":"36105196","id":"PMC_36105196","title":"Fluoxetine increases astrocytic glucose uptake and glycolysis in corticosterone-induced depression through restricting GR-TXNIP-GLUT1 Pathway.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36105196","citation_count":17,"is_preprint":false},{"pmid":"36760500","id":"PMC_36760500","title":"PIN1 and PIN4 inhibition via parvulin impeders Juglone, PiB, ATRA, 6,7,4'-THIF, KPT6566, and EGCG thwarted hepatitis B virus replication.","date":"2023","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36760500","citation_count":16,"is_preprint":false},{"pmid":"16143587","id":"PMC_16143587","title":"VDUP1: a potential mediator of expansion-induced lung growth and epithelial cell differentiation in the ovine fetus.","date":"2005","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16143587","citation_count":16,"is_preprint":false},{"pmid":"35240955","id":"PMC_35240955","title":"Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention.","date":"2022","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/35240955","citation_count":16,"is_preprint":false},{"pmid":"34600826","id":"PMC_34600826","title":"ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.","date":"2021","source":"Journal of diabetes and its complications","url":"https://pubmed.ncbi.nlm.nih.gov/34600826","citation_count":16,"is_preprint":false},{"pmid":"36244583","id":"PMC_36244583","title":"Verapamil inhibits TXNIP-NLRP3 inflammasome activation and preserves functional recovery after intracerebral hemorrhage in mice.","date":"2022","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/36244583","citation_count":16,"is_preprint":false},{"pmid":"34373985","id":"PMC_34373985","title":"Colorectal Cancer Cell Differentiation Is Dependent on the Repression of Aerobic Glycolysis by NDRG2-TXNIP Axis.","date":"2021","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34373985","citation_count":16,"is_preprint":false},{"pmid":"37749991","id":"PMC_37749991","title":"TXNIP activates NLRP3/IL-1β and participate in inflammatory response and oxidative stress to promote deep venous thrombosis.","date":"2023","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/37749991","citation_count":15,"is_preprint":false},{"pmid":"37095099","id":"PMC_37095099","title":"BCR-ABL triggers a glucose-dependent survival program during leukemogenesis through the suppression of TXNIP.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37095099","citation_count":15,"is_preprint":false},{"pmid":"39153986","id":"PMC_39153986","title":"PTBP1 knockdown impairs autophagy flux and inhibits gastric cancer progression through TXNIP-mediated oxidative stress.","date":"2024","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/39153986","citation_count":14,"is_preprint":false},{"pmid":"36517743","id":"PMC_36517743","title":"Ceramide induces pyroptosis through TXNIP/NLRP3/GSDMD pathway in HUVECs.","date":"2022","source":"BMC molecular and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36517743","citation_count":14,"is_preprint":false},{"pmid":"34726138","id":"PMC_34726138","title":"DNA Methylation of TXNIP Independently Associated with Inflammation and Diabetes Mellitus in Twins.","date":"2021","source":"Twin research and human genetics : the official journal of the International Society for Twin Studies","url":"https://pubmed.ncbi.nlm.nih.gov/34726138","citation_count":14,"is_preprint":false},{"pmid":"29852169","id":"PMC_29852169","title":"TXNIP knockdown alleviates hepatocyte ischemia reperfusion injury through preventing p38/JNK pathway activation.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29852169","citation_count":14,"is_preprint":false},{"pmid":"35721021","id":"PMC_35721021","title":"N-Lobe of TXNIP Is Critical in the Allosteric Regulation of NLRP3 via TXNIP Binding.","date":"2022","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35721021","citation_count":14,"is_preprint":false},{"pmid":"33349852","id":"PMC_33349852","title":"Geniposide improves insulin resistance through AMPK-mediated Txnip protein degradation in 3T3-L1 adipocytes.","date":"2021","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/33349852","citation_count":14,"is_preprint":false},{"pmid":"37534934","id":"PMC_37534934","title":"USP5 promotes lipopolysaccharide-induced apoptosis and inflammatory response by stabilizing the TXNIP protein.","date":"2023","source":"Hepatology communications","url":"https://pubmed.ncbi.nlm.nih.gov/37534934","citation_count":13,"is_preprint":false},{"pmid":"30037981","id":"PMC_30037981","title":"Ras Suppresses TXNIP Expression by Restricting Ribosome Translocation.","date":"2018","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30037981","citation_count":13,"is_preprint":false},{"pmid":"27437069","id":"PMC_27437069","title":"Identification of Redox and Glucose-Dependent Txnip Protein Interactions.","date":"2016","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/27437069","citation_count":13,"is_preprint":false},{"pmid":"37506869","id":"PMC_37506869","title":"DNMT1 regulates miR-20a/TXNIP-mediated pyroptosis of retinal pigment epithelial cells through DNA methylation.","date":"2023","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37506869","citation_count":13,"is_preprint":false},{"pmid":"39814099","id":"PMC_39814099","title":"Beyond Redox Regulation: Novel Roles of TXNIP in the Pathogenesis and Therapeutic Targeting of Kidney Disease.","date":"2025","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/39814099","citation_count":13,"is_preprint":false},{"pmid":"40846790","id":"PMC_40846790","title":"Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment.","date":"2025","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/40846790","citation_count":12,"is_preprint":false},{"pmid":"37038114","id":"PMC_37038114","title":"High TXNIP expression accelerates the migration and invasion of the GDM placenta trophoblast.","date":"2023","source":"BMC pregnancy and childbirth","url":"https://pubmed.ncbi.nlm.nih.gov/37038114","citation_count":12,"is_preprint":false},{"pmid":"35771146","id":"PMC_35771146","title":"Galectin-3 induces vascular smooth muscle cells calcification via AMPK/TXNIP pathway.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/35771146","citation_count":12,"is_preprint":false},{"pmid":"36350490","id":"PMC_36350490","title":"Maslinic Acid Suppresses High Glucose-induced Inflammation by Epigenetically Inhibiting TXNIP Expression.","date":"2022","source":"Current medical science","url":"https://pubmed.ncbi.nlm.nih.gov/36350490","citation_count":12,"is_preprint":false},{"pmid":"34855213","id":"PMC_34855213","title":"Antidiabetic effects of quercetin and liraglutide combination through modulation of TXNIP/IRS-1/PI3K pathway.","date":"2021","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/34855213","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53756,"output_tokens":7651,"usd":0.138016},"stage2":{"model":"claude-opus-4-6","input_tokens":11500,"output_tokens":4843,"usd":0.267863},"total_usd":0.405879,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"TXNIP (VDUP1) directly binds to thioredoxin (TRX) via a region spanning amino acids 155–225 of TXNIP; interaction requires Cys32 and Cys35 of TRX and is abolished by mutation of these cysteines to serines, establishing TXNIP as an endogenous inhibitor of TRX.\",\n      \"method\": \"Yeast two-hybrid screen with HeLa cDNA library, deletion and point-mutation mapping\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution-equivalent yeast two-hybrid with site-directed mutagenesis defining the binding interface; foundational paper replicated across many labs\",\n      \"pmids\": [\"10814541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TXNIP (VDUP1) interacts with JAB1 and blocks JAB1-mediated cytoplasmic translocation of p27(kip1), thereby stabilizing p27(kip1) protein levels and inhibiting cell proliferation; VDUP1−/− fibroblasts proliferate faster with reduced p27(kip1).\",\n      \"method\": \"Co-immunoprecipitation, KO fibroblast phenotyping, nuclear export rescue assay, AP-1 reporter assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus genetic KO with defined molecular and cellular phenotype\",\n      \"pmids\": [\"15930262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TXNIP (VDUP1) associates with the β-domain of pVHL and enhances pVHL–HIF1α interaction, mediating nuclear export and degradation of HIF1α via CRM1-dependent pathway; blocking TXNIP nuclear export signal or using leptomycin B prevents HIF1α destabilization and restores cell invasiveness.\",\n      \"method\": \"Co-immunoprecipitation, nuclear export signal mutation, leptomycin B treatment, invasion assays, tumor xenograft\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, mutagenesis of NES, and functional rescue; multiple orthogonal methods in single study\",\n      \"pmids\": [\"18062927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Glucocorticoid receptor (GR) transcriptionally induces TXNIP expression through a functional glucocorticoid response element (GRE) in the TXNIP promoter; GFP-TXNIP overexpression is sufficient to induce apoptosis, and siRNA knockdown of TXNIP inhibits dexamethasone-induced apoptosis in T-cell lymphoma cells.\",\n      \"method\": \"Promoter deletion/mutation analysis, reporter assays, RU486 blockade, RNA interference, GFP-TXNIP overexpression with apoptosis readout\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — promoter mutagenesis, reporter assays, and functional RNAi rescue; multiple orthogonal methods\",\n      \"pmids\": [\"16301999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Thioredoxin binding to TXNIP stabilizes TXNIP protein by protecting it from proteasomal degradation; a Txnip C247S mutant that cannot bind thioredoxin is degraded more rapidly. TXNIP inhibits adipogenesis directly, and this activity requires its PPXY motifs that mediate E3 ubiquitin ligase binding; adipogenic stimulants promote Txnip-thioredoxin dissociation leading to Txnip degradation and permitting adipocyte differentiation.\",\n      \"method\": \"In vitro differentiation assays, proteasome inhibitor studies, mutagenesis of C247S and PPXY motifs, thioredoxin overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical reconstitution with mutagenesis (C247S, PPXY) and functional differentiation readout; single study with multiple orthogonal approaches\",\n      \"pmids\": [\"21705327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TXNIP transcription is induced by adenosine-containing molecules through the carbohydrate response element (ChoRE) in the TXNIP promoter in a glucose-dependent manner; MondoA and Max-like protein X (Mlx) are the transcription factors conveying these signals to the TXNIP promoter.\",\n      \"method\": \"Promoter reporter assays, ChREBP/MondoA overexpression, adenosine analog treatments\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assays with transcription factor identification; single lab study\",\n      \"pmids\": [\"19246513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TXNIP is expressed in nutrient-sensing neurons of the mediobasal hypothalamus (MBH); downregulation of MBH TXNIP by lentiviral shRNA prevents diet-induced obesity and insulin resistance, regulating adipose tissue metabolism and glucose homeostasis.\",\n      \"method\": \"Lentiviral shRNA knockdown in mice, stereotaxic injection, metabolic phenotyping (glucose tolerance, body weight, adiposity)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo loss-of-function with defined metabolic phenotype; single study\",\n      \"pmids\": [\"21508227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TXNIP overexpression in Agrp neurons increases diet-induced obesity and adiposity by decreasing energy expenditure without affecting food intake; Agrp-specific TXNIP deletion protects against diet-induced obesity and improves glucose tolerance, acting through central leptin sensitivity and regulation of lipolysis.\",\n      \"method\": \"Agrp-Ires-cre × Txnip-flox conditional KO and lentiviral gain-of-function, metabolic cage phenotyping, glucose clamps\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional genetic manipulation (KO + OE) in cell-type-specific manner with defined physiological phenotypes\",\n      \"pmids\": [\"22815502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TXNIP promotes internalization and lysosomal degradation of GLUT1, reducing glucose uptake at the plasma membrane; ZFP36 (an mRNA decay factor) induced downstream of hyaluronidase/receptor tyrosine kinase signaling targets TXNIP transcripts for degradation, thereby enriching GLUT1 at the plasma membrane and increasing glycolysis.\",\n      \"method\": \"Unbiased glycolytic driver screen, hyaluronidase treatment of cells and xenografts, ZFP36 mRNA decay assay, GLUT1 surface localization (flow cytometry/imaging), glucose uptake assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (transcriptomics, mRNA decay, surface receptor quantification, xenograft); published in high-impact journal with comprehensive mechanistic validation\",\n      \"pmids\": [\"30197082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TXNIP interacts with class I GLUTs through its C-terminal arrestin (C-ARR) domain; upon intracellular ROS increase, TXNIP robustly binds GLUTs, promoting their surface downregulation and lysosomal degradation via a di-leucine (LL) endocytic motif, thereby suppressing glycolysis, hexosamine biosynthesis, and the pentose phosphate pathway.\",\n      \"method\": \"Co-immunoprecipitation, domain-deletion mapping (C-ARR), mutagenesis of LL endocytic motif, glucose uptake assays, lysosomal degradation assays, metabolic flux analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — domain mutagenesis combined with biochemical interaction mapping and functional metabolic readouts; mechanistically comprehensive\",\n      \"pmids\": [\"38329960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Under ER stress, TXNIP is phosphorylated/activated by CHOP upregulation and shuttles from the nucleus to mitochondria, where it binds mitochondrial Trx2; this releases ASK1 to induce mitochondria-dependent apoptosis and liberates TXNIP to associate with mitochondrial NLRP3 to activate the inflammasome. CHOP deletion blocks TXNIP mitochondrial translocation and suppresses both pathways.\",\n      \"method\": \"Chop−/− and Txnip−/− mice, 68Ga-Galuminox mitochondrial ROS imaging, fractionation, Co-IP, nephrotic syndrome genetic model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic models (two KO strains), molecular imaging, Co-IP, and subcellular fractionation with functional apoptosis/inflammasome readouts\",\n      \"pmids\": [\"35994650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TXNIP directly interacts with PRKAA (AMPKα) to positively regulate its activity, leading to MTORC1 inactivation and nuclear translocation of TFEB, thereby promoting autophagy and fatty acid oxidation in hepatocytes; Txnip-KO mice show impaired autophagy and exacerbated steatohepatitis.\",\n      \"method\": \"Co-immunoprecipitation, Txnip-KO mice fed MCD diet, rapamycin rescue, Atg7 siRNA epistasis, TFEB nuclear translocation imaging\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP establishing direct TXNIP–PRKAA interaction, KO phenotype, and epistasis rescue with multiple genetic and pharmacological tools\",\n      \"pmids\": [\"33190588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Ras suppresses TXNIP protein synthesis by reducing the rate of ribosome translocation through the TXNIP coding sequence; codon randomization/optimization did not relieve repression, but the N-terminal nascent TXNIP polypeptide is the target for Ras-dependent translational repression.\",\n      \"method\": \"Polysome profiling, ribosome transit assay, codon randomization/optimization mutagenesis, Ras activation system\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mechanistic dissection using ribosome profiling and systematic mutagenesis; defines translational elongation as Ras target\",\n      \"pmids\": [\"30037981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"O-GlcNAcylation of TXNIP by OGT in response to high glucose promotes the interaction of TXNIP with NLRP3 in pancreatic β-cells; reducing TXNIP O-GlcNAcylation via OGA overexpression destabilizes this interaction and reduces inflammasome-dependent IL-1β cleavage.\",\n      \"method\": \"O-GlcNAc immunoprecipitation, OGT/OGA overexpression and inhibitor studies, Co-IP of TXNIP–NLRP3, IL-1β ELISA in human and rat islets\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — biochemical identification of PTM (O-GlcNAcylation) on TXNIP with bidirectional manipulation showing effect on TXNIP–NLRP3 interaction and downstream IL-1β; validated in primary human islets\",\n      \"pmids\": [\"31164864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CD36 scavenger receptor mediates ceramide-induced NF-κB activation, which in turn upregulates TXNIP expression and NF-κB-TXNIP signaling in pancreatic β-cells; SSO (irreversible CD36 inhibitor) blocks ceramide-induced TXNIP induction and apoptosis, placing CD36 upstream of TXNIP in this pathway.\",\n      \"method\": \"SSO pharmacological blockade, NF-κB nuclear translocation assay (SN50 peptide), TXNIP gene/protein induction, apoptosis assays in INS-1 cells and primary islets\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — pharmacological epistasis and NF-κB inhibition defining pathway order; single lab\",\n      \"pmids\": [\"26297980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"4-Hydroxynonenal (4-HNE) from foam cells activates PPARδ in vascular endothelial cells, leading to TXNIP upregulation; molecular manipulation of TXNIP expression confirmed its role in foam cell-induced vascular endothelial cell senescence.\",\n      \"method\": \"Co-culture transwell system, 4-HNE scavenging, siRNA/overexpression of TXNIP, PPARδ pharmacological modulation, senescence-associated β-galactosidase assay, immunofluorescence of human carotid plaques\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — RNAi confirmation of TXNIP role plus pathway mapping via PPARδ inhibitors; validated in human tissue\",\n      \"pmids\": [\"25754218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hyperglycemia induces activating histone marks (H3K9ac, H3K4me3, H3K4me1) and reduces repressive H3K27me3 at the TXNIP promoter in kidney mesangial cells and diabetic mouse kidneys; histone acetyltransferase p300 inhibitor C646 reverses glucose-stimulated TXNIP expression, establishing epigenetic histone acetylation as a mechanism of glucose-induced TXNIP transcription.\",\n      \"method\": \"ChIP for histone marks, histone acetyltransferase inhibitor (C646) and HDAC inhibitor (TSA), diabetic mouse kidney model, mesangial cell culture\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with pharmacological perturbation of histone marks in both in vivo and in vitro models; multiple orthogonal approaches\",\n      \"pmids\": [\"26806835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TXNIP directly binds STAT3 (demonstrated by Co-IP) and activates STAT3 signaling; TXNIP overexpression in tubular cells upregulates senescence markers and promotes a profibrotic response, which is suppressed by a STAT3 inhibitor, placing TXNIP upstream of STAT3 in age-related renal fibrosis.\",\n      \"method\": \"Co-immunoprecipitation of TXNIP–STAT3, Txnip-KO mice, TXNIP overexpression in tubular cells, STAT3 inhibitor epistasis\",\n      \"journal\": \"Mechanisms of ageing and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus genetic KO and pharmacological epistasis; single lab\",\n      \"pmids\": [\"33781783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TXNIP contains two C-terminal PPXY motifs that mediate E3 ubiquitin ligase binding; TRAF6 ubiquitylates TXNIP via TRAF6 Cys70-dependent mechanisms, and TXNIP interacts with TRAF6 through its PPxY motif. Sodium butyrate reinforces TRAF6/TXNIP interaction and polyubiquitylation of TXNIP.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitylation assays with TRAF6 C70A mutant, PPxY motif mutant analysis, siRNA knockdown\",\n      \"journal\": \"Cancer medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP and ubiquitylation assays with mutational analysis; single lab\",\n      \"pmids\": [\"31578830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AAV-delivered Txnip prolongs cone photoreceptor survival in retinitis pigmentosa mouse models; the C247S allele (which cannot bind thioredoxin) provides greater rescue than WT Txnip, and the rescue depends on lactate dehydrogenase b (Ldhb), implicating enhanced lactate catabolism as the mechanism by which TXNIP supports cone survival.\",\n      \"method\": \"AAV gene delivery, RP mouse models, C247S allele comparison, Ldhb genetic epistasis, visual acuity testing, mitochondrial health imaging\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic rescue with epistasis (Ldhb KO abrogates effect); C247S allele comparison establishes TRX-independent mechanism\",\n      \"pmids\": [\"33847261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TXNIP shuttles between different subcellular compartments—primarily nucleus under basal conditions and mitochondria under oxidative/ER stress—functioning as a gatekeeper of Trx1 (cytosol) and Trx2 (mitochondria) depending on localization; mitochondrial TXNIP promotes ROS accumulation via Trx2 oxidation, releasing ASK1 to activate apoptosis.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence live-cell imaging, Chop−/− and Txnip−/− mice, mitochondrial ROS probe (68Ga-Galuminox), Co-IP\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — fractionation, imaging, and genetic KO mice with in vivo molecular imaging; multiple orthogonal approaches\",\n      \"pmids\": [\"35994650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NEDD4L E3 ubiquitin ligase ubiquitinates TXNIP, targeting it for degradation; in NASH, decreased NEDD4L causes TXNIP protein accumulation. Accumulated TXNIP binds the N-terminus of the α-helix domain of CHOP and reduces CHOP ubiquitination, thereby increasing CHOP protein stability and promoting ER stress-mediated apoptosis in hepatocytes.\",\n      \"method\": \"Co-IP of TXNIP–CHOP domain mapping, ubiquitination assays, four NASH mouse models, adenoviral shRNA liver-specific knockdown, gain-/loss-of-function\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with domain mapping, ubiquitination assays, and multiple in vivo models; mechanistically comprehensive\",\n      \"pmids\": [\"37153733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BioID proximity labeling identified 31 TXNIP-interacting proteins; many interactions are redox-dependent and disrupted by the C247S mutation (loss of thioredoxin binding), and hyperglycemia dynamically alters the TXNIP interactome, providing a molecular basis for its pleiotropic functions.\",\n      \"method\": \"BioID proximity labeling followed by mass spectrometry, C247S mutant comparison, hyperglycemia treatment\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — proximity-labeling MS interactome with redox-dependent and glucose-dependent validation; single lab\",\n      \"pmids\": [\"27437069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TXNIP positively regulates autophagy in retinal Müller cells under high glucose by inhibiting the PI3K/AKT/mTOR signaling pathway; CRISPR/Cas9 knockout of TXNIP reduces autophagy and apoptosis under high glucose and improves visual response in diabetic retinopathy.\",\n      \"method\": \"CRISPR/Cas9 KO, overexpression, PI3K/AKT/mTOR phosphorylation western blot, electroretinogram\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — CRISPR KO plus overexpression with pathway analysis and in vivo functional readout; single lab\",\n      \"pmids\": [\"33412212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TXNIP suppresses osteochondrogenic differentiation of vascular smooth muscle cells (VSMCs) by inhibiting BMP signaling; smooth muscle cell-specific Txnip deletion (Tagln-Cre; Txnipflox/flox) recapitulates increased atherosclerotic calcification, and BMP inhibitor K02288 abrogates the pro-osteogenic effect of TXNIP suppression in cultured VSMCs.\",\n      \"method\": \"Conditional VSMC-specific KO mice, single-cell RNA-seq, primary VSMC culture, BMP inhibitor epistasis (K02288)\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with scRNA-seq and pharmacological epistasis confirming BMP pathway as mechanistic effector\",\n      \"pmids\": [\"36448450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UHRF1 recruits HDAC1 to the TXNIP promoter and mediates deacetylation of histone H3K9, resulting in transcriptional silencing of TXNIP in renal cell carcinoma; UHRF1 knockdown de-represses TXNIP, and simultaneous TXNIP knockdown rescues the anti-tumor effects of UHRF1 depletion.\",\n      \"method\": \"ChIP for HDAC1 at TXNIP promoter, H3K9 acetylation ChIP, siRNA/shRNA double knockdown, xenograft tumor model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating epigenetic mechanism, epistasis rescue experiment, and in vivo xenograft validation\",\n      \"pmids\": [\"31043707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SIRT6 transcriptionally represses TXNIP by deacetylating H3K9ac and H3K56ac at the TXNIP promoter in microglia and brain microvascular endothelial cells; this SIRT6-mediated TXNIP suppression mediates the protective effects of energy restriction/intermittent fasting on cerebral ischemia.\",\n      \"method\": \"ChIP for H3K9ac and H3K56ac at TXNIP promoter, SIRT6 overexpression, OGD/R cell model, MCAO mouse model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-confirmed histone deacetylation at TXNIP locus with functional rescue; single lab\",\n      \"pmids\": [\"35562171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP5 deubiquitylase interacts with TXNIP (demonstrated by Co-IP) and stabilizes TXNIP protein through deubiquitylation, promoting LPS-induced apoptosis and NLRP3 inflammasome activation; USP5 knockdown reduces TXNIP levels and is reversed by TXNIP overexpression.\",\n      \"method\": \"Deubiquitylase overexpression screen, Co-immunoprecipitation, ubiquitylation assays, siRNA knockdown, epistasis rescue\",\n      \"journal\": \"Hepatology communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP and ubiquitylation assay identifying USP5 as deubiquitylase; single lab with functional validation\",\n      \"pmids\": [\"37534934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TXNIP mRNA is directly regulated by MondoA (not ChREBP) in cervical cancer cells; MondoA overexpression inhibits cell proliferation, migration, and invasion through upregulating TXNIP, placing MondoA as the upstream transcriptional inducer of TXNIP in a cell-type-dependent manner.\",\n      \"method\": \"MondoA/ChREBP overexpression, TXNIP reporter assay, siRNA knockdown, migration/invasion assays\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reporter assays and epistasis rescue identifying transcription factor specificity; single lab\",\n      \"pmids\": [\"31782782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Lactic acid in the tumor microenvironment activates the MondoA–TXNIP transcriptional axis in CD8+ T cells and Tregs via SENP1-mediated de-SUMOylation of MondoA; TXNIP induction impairs TCR/CD28-signal-induced CD8+ T cell activation by restricting glucose uptake; MondoA-deficient Tregs lose immunosuppressive capacity while MondoA-deficient CD8+ T cells show enhanced cytotoxicity.\",\n      \"method\": \"MondoA conditional KO mice, SENP1 manipulation, glucose uptake assays, TCR/CD28 signaling assays, tumor models with anti-PD-1 combination, TXNIP ChIP\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO in specific immune subsets, mechanistic identification of SENP1/SUMOylation upstream of MondoA-TXNIP, and functional in vivo tumor immunology validation\",\n      \"pmids\": [\"40846790\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TXNIP is a multifunctional α-arrestin scaffold protein that primarily inhibits thioredoxin (TRX) by direct disulfide-dependent binding (requiring TRX Cys32/Cys35 and TXNIP Cys247), and additionally shuttles between the nucleus (basal), cytoplasm, and mitochondria depending on redox/ER stress to regulate GLUT1/glucose uptake (via C-ARR domain interaction and LL-motif-driven lysosomal degradation), activate the NLRP3 inflammasome (interaction stabilized by O-GlcNAcylation), promote apoptosis through mitochondrial Trx2-ASK1 release, stabilize p27(kip1) by blocking JAB1, mediate HIF1α nuclear export via pVHL, and suppress BMP signaling in vascular smooth muscle cells; its expression is transcriptionally driven by glucose/MondoA/ChREBP through a carbohydrate response element, induced by glucocorticoid receptor, epigenetically regulated by histone acetylation and SIRT6-mediated deacetylation, and post-translationally controlled by NEDD4L-mediated ubiquitination (degradation) and USP5-mediated deubiquitination (stabilization) as well as thioredoxin-binding-dependent proteasomal protection.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TXNIP is a multifunctional α-arrestin scaffold protein that serves as a central integrator of cellular redox sensing, glucose metabolism, and stress-induced signaling. It directly binds and inhibits thioredoxin (TRX) via a disulfide bond requiring TRX Cys32/Cys35 and TXNIP Cys247, and this interaction reciprocally stabilizes TXNIP protein against proteasomal degradation [PMID:10814541, PMID:21705327]; TXNIP also suppresses glucose uptake by promoting GLUT1 internalization and lysosomal degradation through its C-terminal arrestin domain and a di-leucine endocytic motif [PMID:38329960, PMID:30197082]. Under ER/oxidative stress, TXNIP shuttles from the nucleus to mitochondria where it displaces ASK1 from Trx2 to trigger apoptosis and activates the NLRP3 inflammasome—an interaction enhanced by O-GlcNAcylation—while also regulating autophagy via AMPK activation and mTORC1 inhibition [PMID:35994650, PMID:31164864, PMID:33190588]. TXNIP expression is transcriptionally driven by glucose through the MondoA/ChREBP–ChoRE axis and by glucocorticoid receptor signaling, epigenetically tuned by histone acetylation at its promoter, and post-translationally controlled by NEDD4L-mediated ubiquitination and USP5-mediated deubiquitination [PMID:19246513, PMID:16301999, PMID:26806835, PMID:37153733, PMID:37534934].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"The foundational question of whether TXNIP directly binds thioredoxin was resolved: TXNIP interacts with TRX through a region spanning aa 155–225, requiring the TRX active-site cysteines Cys32/Cys35, establishing TXNIP as the first endogenous TRX inhibitor.\",\n      \"evidence\": \"Yeast two-hybrid screen with deletion and cysteine-to-serine point mutagenesis\",\n      \"pmids\": [\"10814541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TXNIP's own cysteine residue mediating the disulfide bond was not yet identified\", \"functional consequences of TRX inhibition in vivo were not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Beyond redox regulation, TXNIP was shown to control cell proliferation by binding JAB1 and preventing JAB1-mediated cytoplasmic translocation and degradation of the CDK inhibitor p27(kip1), revealing a TRX-independent tumor-suppressive mechanism.\",\n      \"evidence\": \"Reciprocal Co-IP, VDUP1−/− fibroblast phenotyping, nuclear export rescue assay\",\n      \"pmids\": [\"15930262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the JAB1 interaction depends on the same domain as TRX binding was unknown\", \"relevance to in vivo tumor suppression was not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Two parallel advances defined TXNIP's role as a nuclear scaffold and its transcriptional regulation: TXNIP was found to bridge pVHL and HIF1α for CRM1-dependent nuclear export and degradation of HIF1α, and glucocorticoid receptor was identified as a direct transcriptional inducer of TXNIP through a GRE in its promoter, with TXNIP mediating GR-induced apoptosis.\",\n      \"evidence\": \"Co-IP with NES mutagenesis and leptomycin B rescue for pVHL–HIF1α axis; promoter deletion/mutation reporter assays and RNAi rescue for GR–apoptosis axis\",\n      \"pmids\": [\"18062927\", \"16301999\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the pVHL and TRX interactions are mutually exclusive was not determined\", \"identity of TXNIP's NES and its regulation were not fully mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The glucose-sensing transcriptional mechanism was elucidated: MondoA and Mlx were identified as the transcription factors that induce TXNIP through a carbohydrate response element (ChoRE) in the promoter, explaining how TXNIP expression tracks cellular glucose availability.\",\n      \"evidence\": \"Promoter reporter assays with MondoA/ChREBP overexpression and adenosine analog treatment\",\n      \"pmids\": [\"19246513\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type specificity of MondoA versus ChREBP contribution was unresolved\", \"chromatin-level confirmation (e.g., ChIP) was not performed in this study\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The reciprocal stabilization between TXNIP and TRX was demonstrated: TRX binding protects TXNIP from proteasomal degradation via PPXY-motif-dependent E3 ligase recruitment, and TXNIP Cys247 was identified as essential for the disulfide bond; separately, hypothalamic TXNIP was shown to regulate systemic metabolism, as MBH-specific knockdown prevented diet-induced obesity.\",\n      \"evidence\": \"C247S and PPXY mutagenesis with proteasome inhibitor and adipogenesis assays; lentiviral shRNA in mouse MBH with metabolic phenotyping\",\n      \"pmids\": [\"21705327\", \"21508227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific E3 ligase recognizing the PPXY motifs was not identified at this stage\", \"the TRX-independent metabolic functions in neurons were not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Cell-type-specific genetic manipulation in Agrp neurons demonstrated that TXNIP bidirectionally controls energy expenditure and diet-induced obesity through central leptin sensitivity, independent of food intake.\",\n      \"evidence\": \"Agrp-Ires-Cre × Txnip-flox conditional KO and lentiviral gain-of-function with metabolic cage phenotyping\",\n      \"pmids\": [\"22815502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target of TXNIP in Agrp neurons (beyond leptin sensitivity) was not defined\", \"whether TRX inhibition or GLUT regulation mediates the neuronal effect was unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Upstream signaling inputs to TXNIP were expanded: CD36 was placed upstream of NF-κB-dependent TXNIP induction in β-cells during ceramide stress, and PPARδ was identified as a mediator of 4-HNE-induced TXNIP upregulation driving endothelial senescence.\",\n      \"evidence\": \"SSO pharmacological blockade with NF-κB inhibition epistasis in INS-1 cells; co-culture transwell system with PPARδ modulation and senescence assays\",\n      \"pmids\": [\"26297980\", \"25754218\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter binding by NF-κB at the TXNIP locus was not confirmed by ChIP\", \"whether PPARδ directly binds the TXNIP promoter or acts indirectly was unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Three mechanistic dimensions were clarified: (1) glucose-driven histone acetylation (H3K9ac, H3K4me3) at the TXNIP promoter was established as an epigenetic mechanism of TXNIP induction; (2) the C-terminal arrestin domain and di-leucine motif were mapped as the structural basis for GLUT1 endocytosis and lysosomal degradation; (3) BioID proximity labeling revealed a redox-dependent interactome of 31 partners altered by C247S mutation and hyperglycemia.\",\n      \"evidence\": \"ChIP with p300 inhibitor C646 in diabetic kidneys; C-ARR domain deletion and LL motif mutagenesis with glucose uptake assays; BioID-MS with C247S comparison\",\n      \"pmids\": [\"26806835\", \"38329960\", \"27437069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific histone acetyltransferases other than p300 contribute was not resolved\", \"whether the 31 BioID-identified interactors represent direct or proximity-based associations was unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Two modes of TXNIP regulation were defined: ZFP36 was identified as an mRNA decay factor that degrades TXNIP transcripts downstream of receptor tyrosine kinase signaling to permit GLUT1 surface enrichment and glycolysis; separately, Ras was shown to suppress TXNIP at the translational elongation level through a mechanism dependent on the N-terminal nascent polypeptide.\",\n      \"evidence\": \"Unbiased glycolytic driver screen with ZFP36 mRNA decay assays and GLUT1 surface quantification; polysome profiling and ribosome transit assays with codon optimization mutagenesis\",\n      \"pmids\": [\"30197082\", \"30037981\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The RNA-binding protein or ribosome factor mediating Ras-dependent translational stalling was not identified\", \"whether ZFP36 and Ras pathways converge was not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"O-GlcNAcylation was identified as a post-translational modification that stabilizes the TXNIP–NLRP3 interaction in pancreatic β-cells, with UHRF1/HDAC1-mediated H3K9 deacetylation separately established as an epigenetic silencing mechanism for TXNIP in renal cell carcinoma.\",\n      \"evidence\": \"O-GlcNAc immunoprecipitation with OGT/OGA manipulation and IL-1β ELISA in human islets; ChIP for HDAC1 at TXNIP promoter with epistasis knockdown and xenograft validation\",\n      \"pmids\": [\"31164864\", \"31043707\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific O-GlcNAcylation sites on TXNIP were not mapped\", \"whether UHRF1-mediated silencing operates in non-cancer contexts was not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"TXNIP was shown to directly bind and activate AMPKα, leading to mTORC1 inactivation and TFEB nuclear translocation to promote autophagy and fatty acid oxidation in hepatocytes; Txnip-KO mice developed exacerbated steatohepatitis.\",\n      \"evidence\": \"Co-IP of TXNIP–PRKAA, Txnip-KO mice on MCD diet, rapamycin rescue, Atg7 siRNA epistasis\",\n      \"pmids\": [\"33190588\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TXNIP activates AMPK through allosteric binding or by affecting upstream kinases was not resolved\", \"the interplay between TRX inhibition and AMPK activation was not dissected\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Multiple new regulatory connections were established: AAV-delivered TXNIP C247S (TRX-binding-deficient) rescued cone photoreceptors in retinitis pigmentosa models via Ldhb-dependent lactate catabolism; TXNIP was found to bind STAT3 and promote renal fibrosis/senescence; TRAF6 was identified as a ubiquitin ligase for TXNIP via its PPXY motifs; and MondoA (not ChREBP) was confirmed as the cell-type-specific transcriptional inducer in cervical cancer.\",\n      \"evidence\": \"AAV gene delivery with C247S allele and Ldhb epistasis in RP mice; Co-IP of TXNIP–STAT3 with Txnip-KO mice; Co-IP and ubiquitylation assays with TRAF6 C70A mutant; MondoA reporter assays and siRNA epistasis\",\n      \"pmids\": [\"33847261\", \"33781783\", \"31578830\", \"31782782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TXNIP's lactate-catabolism-promoting activity operates in tissues other than photoreceptors was unknown\", \"the STAT3 binding interface on TXNIP was not mapped\", \"whether TRAF6 is the physiological E3 ligase in metabolic tissues was not confirmed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The stress-dependent subcellular trafficking of TXNIP was defined: TXNIP resides in the nucleus basally but shuttles to mitochondria under oxidative/ER stress (CHOP-dependent), where it displaces ASK1 from Trx2 to trigger apoptosis and engages NLRP3 for inflammasome activation; SIRT6 was identified as a TXNIP transcriptional repressor via H3K9ac/H3K56ac deacetylation; and VSMC-specific Txnip deletion increased atherosclerotic calcification through de-repressed BMP signaling.\",\n      \"evidence\": \"Subcellular fractionation with Chop−/− and Txnip−/− mice and 68Ga-Galuminox imaging; ChIP for H3K9ac/H3K56ac with SIRT6 overexpression; Tagln-Cre Txnipflox/flox mice with scRNA-seq and BMP inhibitor epistasis\",\n      \"pmids\": [\"35994650\", \"35562171\", \"36448450\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The signal or kinase mediating CHOP-dependent TXNIP phosphorylation/mitochondrial import was not identified\", \"whether SIRT6 regulation is tissue-specific or generalizable was not addressed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The E3 ligase NEDD4L was identified as the primary ubiquitin ligase targeting TXNIP for degradation in NASH; accumulated TXNIP reciprocally stabilizes CHOP by binding its N-terminal α-helix domain and reducing CHOP ubiquitination. Separately, USP5 was identified as a deubiquitylase that stabilizes TXNIP to promote NLRP3 inflammasome activation.\",\n      \"evidence\": \"Co-IP with TXNIP–CHOP domain mapping and ubiquitination assays in four NASH mouse models; deubiquitylase screen with Co-IP and epistasis rescue\",\n      \"pmids\": [\"37153733\", \"37534934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NEDD4L and USP5 compete for TXNIP regulation in the same cellular context was not tested\", \"the ubiquitin chain type on TXNIP was not fully characterized\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The MondoA–TXNIP axis was shown to operate as a metabolic checkpoint in tumor immunity: lactic acid activates MondoA via SENP1-mediated de-SUMOylation, inducing TXNIP in CD8+ T cells to restrict glucose uptake and impair TCR/CD28 signaling, while the same axis maintains Treg immunosuppressive function.\",\n      \"evidence\": \"MondoA conditional KO mice in immune subsets, SENP1 manipulation, glucose uptake and TCR signaling assays, tumor models with anti-PD-1\",\n      \"pmids\": [\"40846790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether direct TXNIP–GLUT1 interaction mediates T cell glucose restriction or an alternative mechanism operates was not confirmed\", \"the TXNIP O-GlcNAcylation and inflammasome axis in the tumor immune microenvironment was not integrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of TXNIP's multi-domain scaffold interactions (no crystal or cryo-EM structure of TXNIP in complex with any partner), the identity of the kinase or signal mediating CHOP-dependent TXNIP phosphorylation and mitochondrial import, and how competing post-translational modifications (O-GlcNAcylation, ubiquitination by NEDD4L/TRAF6, deubiquitination by USP5, TRX-mediated stabilization) are coordinately regulated in different tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of TXNIP or its complexes exists\", \"The specific phosphorylation sites driving mitochondrial translocation are unmapped\", \"Tissue-specific hierarchy of TXNIP's E3 ligases (NEDD4L vs TRAF6) and deubiquitylases is unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 9, 11, 24]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 9, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 20]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [10, 20]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 10, 20]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [8, 9, 19]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [11, 23]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3, 10, 20]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [13, 29]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 21, 27]}\n    ],\n    \"complexes\": [\n      \"NLRP3 inflammasome\"\n    ],\n    \"partners\": [\n      \"TXN\",\n      \"TXN2\",\n      \"NLRP3\",\n      \"GLUT1\",\n      \"JAB1\",\n      \"PRKAA1\",\n      \"NEDD4L\",\n      \"USP5\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}